Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

GPS Compared With BAT in AML CR2/CR2p

GPS Compared With BAT in AML CR2/CR2p
Condition:   Acute Myeloid Leukemia
Interventions:   Biological: Galinpepimut-S;   Drug: Best Available Therapy
Sponsor:   Sellas Life Sciences Group

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 16, 2020 / by / in